| Product Code: ETC13363391 | Publication Date: Apr 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 150 | No. of Figures: 55 | No. of Tables: 32 |
North America Opioid Use Disorder Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 North America Opioid Use Disorder Market Overview |
3.1 North America Regional Macro Economic Indicators |
3.2 North America Opioid Use Disorder Market Revenues & Volume, 2021 & 2031F |
3.3 North America Opioid Use Disorder Market - Industry Life Cycle |
3.4 North America Opioid Use Disorder Market - Porter's Five Forces |
3.5 North America Opioid Use Disorder Market Revenues & Volume Share, By Countries, 2021 & 2031F |
3.6 North America Opioid Use Disorder Market Revenues & Volume Share, By Treatment Type, 2021 & 2031F |
3.7 North America Opioid Use Disorder Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.8 North America Opioid Use Disorder Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
3.9 North America Opioid Use Disorder Market Revenues & Volume Share, By Therapy Type, 2021 & 2031F |
4 North America Opioid Use Disorder Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 North America Opioid Use Disorder Market Trends |
6 North America Opioid Use Disorder Market, 2021 - 2031 |
6.1 North America Opioid Use Disorder Market, Revenues & Volume, By Treatment Type, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 North America Opioid Use Disorder Market, Revenues & Volume, By Medication-Assisted Treatment (MAT), 2021 - 2031 |
6.1.3 North America Opioid Use Disorder Market, Revenues & Volume, By Behavioral Therapy, 2021 - 2031 |
6.1.4 North America Opioid Use Disorder Market, Revenues & Volume, By Detoxification, 2021 - 2031 |
6.1.5 North America Opioid Use Disorder Market, Revenues & Volume, By Support Programs, 2020 - 2028 |
6.2 North America Opioid Use Disorder Market, Revenues & Volume, By Drug Class, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 North America Opioid Use Disorder Market, Revenues & Volume, By Buprenorphine, 2021 - 2031 |
6.2.3 North America Opioid Use Disorder Market, Revenues & Volume, By Methadone, 2021 - 2031 |
6.2.4 North America Opioid Use Disorder Market, Revenues & Volume, By Naltrexone, 2021 - 2031 |
6.2.5 North America Opioid Use Disorder Market, Revenues & Volume, By Naloxone, 2021 - 2031 |
6.3 North America Opioid Use Disorder Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 North America Opioid Use Disorder Market, Revenues & Volume, By Hospitals, 2021 - 2031 |
6.3.3 North America Opioid Use Disorder Market, Revenues & Volume, By Clinics, 2021 - 2031 |
6.3.4 North America Opioid Use Disorder Market, Revenues & Volume, By Specialty Centers, 2021 - 2031 |
6.3.5 North America Opioid Use Disorder Market, Revenues & Volume, By Online Pharmacies, 2021 - 2031 |
6.4 North America Opioid Use Disorder Market, Revenues & Volume, By Therapy Type, 2021 - 2031 |
6.4.2 North America Opioid Use Disorder Market, Revenues & Volume, By Long-Term, 2021 - 2031 |
6.4.3 North America Opioid Use Disorder Market, Revenues & Volume, By Outpatient, 2021 - 2031 |
6.4.4 North America Opioid Use Disorder Market, Revenues & Volume, By Residential, 2020 - 2028 |
6.4.5 North America Opioid Use Disorder Market, Revenues & Volume, By Harm Reduction, 2020 - 2028 |
7 North America Opioid Use Disorder Market, By Countries, 2021 - 2031 |
7.1 Overview & Analysis |
7.2 North America Opioid Use Disorder Market, Revenues & Volume, By Treatment Type, 2021 - 2031 |
7.2.1 United States (US) Opioid Use Disorder Market, Revenues & Volume, By Treatment Type, 2021 - 2031 |
7.2.2 Canada Opioid Use Disorder Market, Revenues & Volume, By Treatment Type, 2021 - 2031 |
7.2.3 Rest of North America Opioid Use Disorder Market, Revenues & Volume, By Treatment Type, 2021 - 2031 |
7.3 North America Opioid Use Disorder Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
7.3.1 United States (US) Opioid Use Disorder Market, Revenues & Volume, By Drug Class, 2021 - 2031 |
7.3.2 Canada Opioid Use Disorder Market, Revenues & Volume, By Drug Class, 2021 - 2031 |
7.3.3 Rest of North America Opioid Use Disorder Market, Revenues & Volume, By Drug Class, 2021 - 2031 |
7.4 North America Opioid Use Disorder Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
7.4.1 United States (US) Opioid Use Disorder Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
7.4.2 Canada Opioid Use Disorder Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
7.4.3 Rest of North America Opioid Use Disorder Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
7.5 North America Opioid Use Disorder Market, Revenues & Volume, By Therapy Type, 2021 - 2031 |
7.5.1 United States (US) Opioid Use Disorder Market, Revenues & Volume, By Therapy Type, 2021 - 2031 |
7.5.2 Canada Opioid Use Disorder Market, Revenues & Volume, By Therapy Type, 2021 - 2031 |
7.5.3 Rest of North America Opioid Use Disorder Market, Revenues & Volume, By Therapy Type, 2021 - 2031 |
8 North America Opioid Use Disorder Market Key Performance Indicators |
9 North America Opioid Use Disorder Market - Export/Import By Countries Assessment |
10 North America Opioid Use Disorder Market - Opportunity Assessment |
10.1 North America Opioid Use Disorder Market Opportunity Assessment, By Countries, 2021 & 2031F |
10.2 North America Opioid Use Disorder Market Opportunity Assessment, By Treatment Type, 2021 & 2031F |
10.3 North America Opioid Use Disorder Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
10.4 North America Opioid Use Disorder Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10.5 North America Opioid Use Disorder Market Opportunity Assessment, By Therapy Type, 2021 & 2031F |
11 North America Opioid Use Disorder Market - Competitive Landscape |
11.1 North America Opioid Use Disorder Market Revenue Share, By Companies, 2022 |
11.2 North America Opioid Use Disorder Market Competitive Benchmarking, By Operating and Technical Parameters |
12 Top 10 Company Profiles |
13 Recommendations |
14 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here